Improved Pregnancy Outcomes for Women with SLE

Other factors that have likely contributed to the improved outcomes include better diagnosis and referral of patients with mild disease to rheumatologists, as well as counseling of women to attempt pregnancy when disease is quiescent. Whatever the causes, the findings suggest that previous concerns about mortality associated with pregnancy in women with SLE are no longer applicable.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

Mehta B, Luo Y, Xu J, et al. Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: A cross-sectional analysis. Ann Intern Med. 2019 Jul 9. [Epub ahead of print]

How to minimize the risks of pregnancy for women with SLE

Michrochimerism research offers insights into several autoimmune conditions

The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

A Better Family Plan

The Chimeric Self

Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

Treat to Target: Rheumatoid Arthritis in Pregnant Patients

Related Articles